AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX)

CUSIP: 00972G108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / SPONSORED ADR
Total 13F shares
10,076,550
Share change
-44,141
Total reported value
$1,712,859
Price per share
$0.17
Number of holders
16
Value change
-$7,296
Number of buys
6
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 00972G108?
CUSIP 00972G108 identifies AKTX - AKARI THERAPEUTICS PLC - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q2 2023

As of 30 Jun 2023, AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,076,550 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, Omnia Family Wealth, LLC, NEA Management Company, LLC, Cerity Partners LLC, RENAISSANCE TECHNOLOGIES LLC, Cresset Asset Management, LLC, LPL Financial LLC, MILLENNIUM MANAGEMENT LLC, Hikari Power Ltd, and Bryn Mawr Capital Management, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.